Oculus Innovative Sciences, Inc. Announces SFDA Approval of Microcyn

March 31, 2008 -- Oculus Innovative Sciences (NSDQ: OCLS) has received an approval from the SFDA of its Microcyn® Technology for treatment of several acute and chronic wounds including ulcers, cuts, contusions and burns. Microcyn is a super-oxygenated form of water that is not toxic, but highly effective against bacteria, viruses, mold and spores. Microcyn combines its anti-infective properties with the ability to promote wound healing. More details...

MORE ON THIS TOPIC